Next Article in Journal
De Novo Transcriptome Assembly of Two Microsorum Fern Species Identifies Enzymes Required for Two Upstream Pathways of Phytoecdysteroids
Previous Article in Journal
Titanium Dioxide, but Not Zinc Oxide, Nanoparticles Cause Severe Transcriptomic Alterations in T98G Human Glioblastoma Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Expression of Lymphatic Markers in the Berger’s Space and Bursa Premacularis

1
Department of Ophthalmology, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki-City 569-8686, Osaka, Japan
2
Nakamura Eye Clinic, 3-6-22 Chuo, Matsumoto-City 390-0811, Nagano, Japan
3
Department of Innovative Medicine, Graduate School of Medicine, Osaka Medical College, 2-7 Daigaku-machi, Takatsuki-City 569-8686, Osaka, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(4), 2086; https://doi.org/10.3390/ijms22042086
Submission received: 11 December 2020 / Revised: 13 February 2021 / Accepted: 16 February 2021 / Published: 19 February 2021
(This article belongs to the Section Molecular Biology)

Abstract

:
We previously reported that the bursa premacularis (BPM), a peculiar vitreous structure located above the macula, contains numerous cells expressing markers of lymphatic endothelial cells, such as podoplanin and LYVE-1. Herein, we examined the expression of lymphatic markers in the Berger’s space (BS), BPM, and vitreous core (VC). BS, BPM, and VC specimens were selectively collected in macular hole and epiretinal membrane patients during vitrectomy and were then immunostained with antibodies for podoplanin, LYVE-1, and fibrillin-1 and -2. By visualization using triamcinolone acetonide, the BS was recognized as a sac-like structure with a septum located behind the lens as well as BPM. Those tissues adhered to the lens or retina in a circular manner by means of a ligament-like structure. Immunostaining showed intense expression of podoplanin and LYVE-1 in the BS. Both BS and BPM stained strongly positive for fibrillin-1 and -2. The VC was faintly stained with antibodies for those lymph-node markers. Our findings indicate that both BS and BPM possibly belong to the lymphatic system, such as lymph nodes, draining excess fluid and waste products into lymphatic vessels in the dura mater of the optic nerve and the ciliary body, respectively, via intravitreal canals.

1. Introduction

The vitreous body is a hydrogel with very high water content ranging from 98 to 99%, which impedes the use of usual histological methods to determine the structure [1,2]. Thus, most of the fine structures of the vitreous remain obscured. In 1971, using a modified slit-lamp camera, Eisner observed membranous structures in the vitreous, named “tractae” (i.e., tracts), that coursed from the region around the lens in a circumferential pattern, parallel to the vitreous cortex, and inserted at the posterior pole [3,4]. Worst and Los subsequently reported visualizing approximately 120 cisterns within the vitreous body after injecting it with colored ink (Magic® Color, Royal Sovereign; red, blue, and white) [5] and postulated that the tracts reported by Eisner constituted the wall of the cisterns, all of which interconnected in the middle of the vitreous, forming the cisternal system of Worst [6]. Both Eisner and Worst stored the eye specimens in a balanced salt solution at 4 °C for several days before initiating dissection of the eye, which facilitated removal of the retina from the vitreous [5].
In 1975, Worst first reported the bursa premacularis (BPM) to be a part of the cisternal system with a peculiar sac-like structure located in the premacular vitreous [5,7]. Worst conjectured that the BPM might protect the macula in both hydrodynamic and biochemical senses [8], although the anatomical structure and physiological role of the BPM have yet to be fully elucidated.
Our recent study exhibited that the vitrectomy specimens of the thin tissue remaining on the macula after induction of posterior vitreous detachment (PVD) contained numerous cells, including those expressing lymphatic markers, such as podoplanin and lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) [9]. This thin tissue has generally been considered the remaining vitreous cortex. However, our findings indicated the possibility that it was the BPM and that it that might have properties similar to lymph nodes [9].
The Berger’s space (BS) is another accessory structure of the vitreous body, and it is a tiny anatomical gap located between the lens and the anterior hyaloid membrane (AHM) [10]. It has been reported that the BS is where various objects accumulate, such as blood, inflammatory cells, pigments, and proteinaceous materials including amyloid [11,12,13,14,15]. Using Vitreokontrast suspension (i.e., a dispersed suspension of nonorganic barium sulfate) with sequential removal of the anterior vitreous cortex up to the posterior lens capsule, Kislitsyna et al. showed the possibility that the retrolental bursa (sac) with an anterior wall attached to the lens existed, rather than the retrolental space (i.e., the BS), with no anterior wall (YouTube. Available at: http://www.evrs.eu/on-the-inner-side-of-lens-anatomic-and-topographic-features-of-anterior-vitreous-2/ (accessed on 31 May 2019)) [16,17].
In this present study, we examine the expression of lymphatic markers (podoplanin, LYVE-1, and fibrillin-1 and -2) in specimens of the BS (or its wall) and the BPM that were selectively collected during vitrectomy and report the results of immunostaining of these two tissues, with a discussion on the possibility that they might have functions similar to the lymphatic system, such as lymph nodes.

2. Results

2.1. Anatomical Similarities between the BS and the BPM Observed during Specimen Collection

In all patients, the BPM was observed using triamcinolone acetonide (TA) to be an oval or round-shaped thin tissue with a size of 5 to 6 disc diameters on the macula (Figure 1a). Since the central part of the adhesion between the BPM and the retina was weak, holes were easily created in the anterior and posterior walls by surgically scraping with a diamond scraper (Figure 1b,c). The BPM was then removed from the retinal surface via aspiration of the edge of the hole in the anterior wall with a vitreous cutter. It was relatively easy to detach the central part of the BPM from the retina, even though strong adhesion with a circular ligamentous structure was observed in the periphery (Figure 1c; thin black arrows). This adhesion to the retina extended from the BPM to the Martegiani area with a septal structure. The Martegiani area was located around the optic disc, with a size of approximately 2 disc diameters. By further lifting the combined specimen of the BPM and the Martegiani area with a vitreous cutter, the circular adhesions of the specimen were removed. The specimen was then released into the vitreous cavity and was selectively collected by cutting into multiple small pieces with a vitreous cutter (Figure 1d). The time required for collection of the BPM specimen was approximately 1 min, with no increase in invasiveness or complications.
The BS was visualized by injecting it with TA (Figure 2a). The injection of TA showed a septum-like structure dividing the BS into a two-thirds temporal and one-third nasal formation (Figure 2b; black arrowheads). The central part of the BS was easily detached from the lens capsule via aspiration with a vitreous cutter, even though a firm circular adhesion with a ligamentous structure was observed in the periphery. By further lifting the posterior wall of the BS with the vitreous cutter, the circular adhesion was removed. The BS specimen was then selectively collected after cutting it into multiple small pieces by use of the vitreous cutter. The intraoperative findings indicate that the BS and the BPM had similar elastic properties.

2.2. Immunostaining of the BPM and the Vitreous Core (VC) with Antibodies for Fibrillin-1 and -2

In Cases 1–4, the BPM specimen was intensely stained with antibodies for fibrillin-1 and -2, whereas the VC was faintly stained (Figure 3a and Figure 4a). While some BPM specimens were diffusely stained with antibodies for fibrillin-1 and -2 (Figure 3b: Cases 2 and 3; Figure 4b: Case 4), others exhibited an annular staining pattern (Figure 3b: Case 1; Figure 4b: Cases 1 and 3).

2.3. Immunostaining of the BS, BPM, and VC with Antibodies for Fibrillin-1 and -2, Podoplanin, and LYVE-1

In Cases 5 to 8, the BS and BPM stained positive for fibrillin-1 and -2 (Figure 5b,c) whereas the VC stained negative (Figure 5a). The BS and BPM stained more intensely for podoplanin and LYVE-1 (Figure 5b,c) than did the VC (Figure 5a). Moreover, the staining patterns in BS and BPM were remarkably similar in appearance (Figure 5b,c).

3. Discussion

Although knowledge about the vitreous body has tremendously increased over the past several decades, the vitreous is still the most enigmatic tissue in the eye [18] due to its transparency and high water content, as mentioned above [1]. Hence, there has been a continuing controversy regarding the anatomical and physiological properties of the vitreous.
After a PVD is induced during vitrectomy, a thin membranous tissue remains adhered to the surface of the macular retina and it is usually associated with an oval or round defect in the posterior hyaloid membrane [19,20]. It has been generally accepted that this thin tissue is the posterior wall of the posterior precortical vitreous pocket, which Kishi et al. reported in 1990 using Trump’s fixed eyes and the fluorescein staining technique [21]. The posterior precortical vitreous pocket has been considered the same space as the BPM, and the posterior wall of the posterior precortical vitreous pocket has been regarded as the vitreous cortex [22,23]. However, in 1978, Worst described and assumed that, after complete PVD, the BPM might occasionally remain adhered to the macula, connecting to the canal extruded from the collapsed vitreous through the premacular oval defect in the posterior hyaloid membrane [8].
In 1989, Sebag also observed that the vitreous remained attached to the macula even in the presence of PVD, extruding through the hole in the posterior hyaloid membrane with fibers inserting into the macula [1,24]. Kakehashi et al. observed the vitreous with PVD associated with a premacular oval defect via the use of in vivo slit-lamp biomicroscopy and obtained findings similar to those described by Worst and Sebag [25]. Kakehashi et al. further reported that the Tyndall effect, an optical phenomenon, was mostly observed in the premacular vitreous without PVD, in which the BPM was supposed to be present, thus indicating that the formed vitreous gel occupied that space [26]. Consequently, we considered that the optically empty space that is observed by swept-source optical coherence tomography (SS-OCT) [27] is not actually empty.
In 2012, Polak, Ringens, and Worst observed the migration of intravitreally injected TA into the remaining thin tissue on the macula after artificial PVD [28] and postulated that this thin tissue might be the BPM, as the configuration of the migrated TA closely resembled that of the BPM and its connecting cisterns (i.e., the corona petaliformis of Worst), which was observed in vitro using the ink injection technique [5].
It has been generally recognized that idiopathic epiretinal membrane (ERM) is caused by fibrotic change of the posterior vitreous cortex remaining on the macula after complete PVD [19,22,29]. However, in 1975, Worst postulated that the BPM remained attached to the macula without connection to the collapsed vitreous after complete PVD and might contract, thus causing ERM [8]. In 1995, Okada et al. reported that ERM histologically consisted of collagen layer with or without a flattened cell layer [30]. Thus, we speculate that idiopathic ERM might be caused by fibrotic change of the complex of the posterior hyaloid membrane and the BPM (or its posterior wall) or the posterior hyaloid membrane alone that remains on the macula after PVD.
Vitreoschisis has been considered a lamellar split in the posterior vitreous cortex resulting from anomalous PVD [31,32]. Vitreoschisis and anomalous PVD were associated with various pathological conditions, such as a macular hole (MH), ERM, and proliferative diabetic retinopathy (PDR) [32]. Based on three-dimensional OCT (3D-OCT) findings, Sebag postulated that a multilamellar structure (i.e., of at least three layers) might be present in the posterior vitreous cortex, predisposing to vitreoschisis [18,32]. Sebag et al. [32] and Gupta et al. [33] also observed a lamellar structure of the posterior vitreous cortex in a monkey eye via staining with fluorescein-conjugated Agaricus bisporus agglutinin (ABA) lectin. However, the vitreous cortex above the fovea is extremely thin or absent [4,34,35,36]. Therefore, we assume that a multilamellar structure demonstrated by 3D-OCT imaging and by the fluorescein-labeled staining method might consist of the anterior and posterior walls of the BPM and the posterior hyaloid membrane and that vitreoshisis might be caused by fibrotic changes of these three membranous tissues associated with partial adhesion among them.
Kislitsyna et al. meanwhile reported that, after the removal of the anterior vitreous cortex in cadaver eyes, several membranes (i.e., four, on average; a multilamellar structure similar to the premacular vitreous) were detected covering the BS and with an ability to exfoliate (YouTube. Available at: https://www.evrs.eu/on-the-inner-side-of-lens-anatomic-and-topographic-features-of-anterior-vitreous-2/; minutes 2:03–5:00 (accessed on 31 May 2019)) [16,17]. Accordingly, the BS appears to share common anatomical features with the BPM.
The lymphatic vessels play vital physiological roles in tissue fluid balance, excretion of waste metabolites, immune defense, and transport of lipids [37]. One critical function of lymphatic vessels is to return excess interstitial fluid, which continually leaks out of the bloodstream through the permeable walls of blood capillaries, back to the blood circulation [38]. Only a few regions, including the bone marrow, epidermis, cartilage, and ocular tissues except for the ocular adnexa, are generally thought to be devoid of lymphatic vessels [39].
It has previously been reported that the central nervous system is an organ devoid of lymphatic vessels, thus raising long-standing questions about how excess water and waste metabolites are removed from the brain [40]. In 2012, Iliff et al. discovered a series of channels surrounding cerebral blood vessels that remove excess interstitial fluid and waste products such as amyloid-β, thus preventing the onset of Alzheimer disease [41]. This paravascular drainage system, managed by aquaporin-4 (AQP4) expressing astrocytes, was termed the glymphatic system [42]. Moreover, in 2015, Aspelund et al. [40] and Bucchieri et al. [43] discovered classic lymphatic vessels located in the dura mater of the brain meninges. In addition, the glymphatic system enables the brain to drain the interstitial fluid into the meningeal lymphatic vessels, draining to the deep cervical lymph nodes [44,45].
The retina, which is anatomically and developmentally known as an extension of the brain [46], has also been thought to be devoid of lymphatic vessels [47]. However, in 2015, Wostyn et al. and Denniston et al. reported the existence of a paravascular space (i.e., the glymphatic system) in the retina and the optic nerve, thus suggesting that, similar to Alzheimer’s disease, glymphatic pathway dysfunction might contribute to deficient amyloid-β clearance from the retina, ultimately causing glaucoma and age-related macular degeneration [48,49,50,51]. Similar to in the central nervous system, classic lymphatic vessels were recently found in the dura mater of the optic nerve [52].
Although the BPM has been regarded as an empty space, as mentioned above [27], our recent immunostaining study showed that the BPM might be a parenchymal tissue containing numerous cells expressing lymphatic endothelial cell markers podoplanin and LYVE-1; mast cell markers tryptase and chymase; and ER-TR7, a reticular fibroblast marker antibody [9]. Podoplanin and LYVE-1 are also implicated in uveal melanoma [53]. In this present study, the BPM was more intensely stained with antibodies for fibrillin-1 and -2 than was the VC (Figure 3, Figure 4 and Figure 5). Fibrillin-1 and -2 are the components of the lymph node conduits [54] that transport fluid containing immune cells and small molecules in the lymph nodes [55,56]. The conduit system has a collagen core that is surrounded by microfibrils containing fibrillin-1 and -2 and reticular fibroblasts expressing ER-TR7 [57,58]. It appeared that the entire BPM was stained, but since this specimen was whole-mounted, it is likely that only the surface of the BPM was stained. The lymph node sinuses are lined by a single layer of lymphatic endothelial cells expressing podoplanin and LYVE-1 [59,60]. Namely, the BPM specimens obtained during vitrectomy appeared to express several lymph node markers [9].
In our previous study, mast cells, which resided in the lymph nodes [61], were found in the BPM [9]. Worst showed that the BPM was expandable (YouTube. Available at: http://www.surgerytheater.com/video/9822/The-Vitreous-Body-Enigma-a-Paradigm-Shift-by-Prof-Dr-Jan-Worst; (accessed on 6 July 2012)), while the capsule of the lymph nodes has high distensibility [62,63]. Worst also showed that the cisternal system including the BPM collapsed after the posterior hyaloid membrane was removed from the surface, while the lymphatic vessels and the lymph nodes occasionally collapsed under non-physiological conditions [63,64,65]. Using a scanning electron microscope, Jongebloed et al. showed that a few bacteria were trapped in the BPM [66], which is a well-known phenomenon observed in the lymph nodes [67,68]. Consequently, our series of studies and a review of the literature seem to indicate the possibility that the BPM has similar properties to lymph nodes.
The findings in this present study showed that both the BS and the BPM are intensely stained with lymphatic markers, such as podoplanin, LYVE-1, and fibrillin-1 and -2 (Figure 5). The BS and the BPM closely resembled each other in regard to their staining patterns (Figure 3, Figure 4 and Figure 5) [9]. Furthermore, our intraoperative findings showed that the BS and the BPM had similar elastic properties. Kishi et al. also reported that the posterior wall of the posterior precortical vitreous pocket, which we consider the BPM, was elastic [35]. Judging from SS-OCT imaging, the BS and the BPM appear to be empty space, as previously described [35,36,69]; however, OCT images of the cortex of lymph nodes have been depicted as a low-scattering region compared with the surrounding connective tissue [70]. Therefore, it is possible that the BS could be composed of parenchymal tissue such as lymph nodes rather than empty space filled with fluid, as with the BPM [27].
Hemorrhage in the BS is occasionally observed after an episode of ocular trauma [11]. Moreover, studies have reported the occurrence of a sharply demarcated hemorrhage in the premacular region associated with several vitreoretinal diseases, such as PDR, Valsalva retinopathy, and Terson syndrome [71,72,73,74]. Premacular hemorrhage is thought to be located in the subhyaloid or sub-internal limiting membrane space [72,75]. However, based on the distribution of the blood, Jongebloed et al. postulated that premacular hemorrhage might occur within the BPM [76]. Meyer reported that the dome-shaped membrane located in front of a premacular hemorrhage was difficult to penetrate by yttrium aluminum garnet (YAG) laser [75], which we assume is the result of the elastic properties of the BPM capsule.
We previously reported that the removal of a hemorrhage adhering to the posterior lens capsule (presumably located within the BS) required resection with a vitreous cutter placed near the lens [77]. Moreover, Fine et al. and Shimada et al. reported that TA, which migrated (or was injected) into the BPM, could not be aspirated and that excision of the surrounding structure with a vitreous cutter was required to remove the TA [78,79]. Hence, it seems likely that the BS and the BPM might have sac-like structures with very similar features, thus exhibiting a mirror image across the vitreous body.
The periphery of the BS attaches to the posterior lens capsule via a thickened circular adhesion known as Wieger’s ligament [80,81]. The main component of Wieger’s ligament are oxytalan tissue fibers, and fibrillin-1 and -2 are known to be markers of those fibers [82]. However, Worst et al. reported the discovery of a perimacular vitreoretinal attachment ring (about 6 mm in diameter) that provides relatively strong adhesion between the BPM and the peripheral macula [83]. Shimada et al. reported that the BPM and Martegiani area were surrounded by a dense network of fibrils [84]. Our intraoperative findings showed that all three of these tissues had comparatively strong circular adhesions at the periphery with ligament-like structures, which were able to be separated from the retina or lens by aspiration with a vitreous cutter.
Using the ink-injection technique, Worst et al. showed that a septal structure, named the septum interpapillo-maculare, was clearly visible between the BPM and the Martegiani area [5,83]. Using SS-OCT, Itakura et al. reported a septal structure similar to the one observed by Worst [22]. When TA was injected into the BS, we observed that a septum-like structure divided the BS into a two-thirds temporal and a one-third nasal formation (Figure 2b, black arrowheads), presumably an extension of the septum interpapillo-maculare reported by Worst (YouTube. Available at: https://www.ophtec.com/company/blog/2018/10/849379-top-3-video-s-of-prof-dr-worst-on-youtube; 1. “The Vitreous Body Enigma. A Paradigm Shift” by Prof. Dr. Jan Worst; minutes 7:06–7:46 (accessed on 17 April 2012) [5].
Based on in vitro examination of the vitreous structure, Eisner theorized that the tracts of Eisner regulated the direction of intravitreal fluid transport [4,5]. Using the ink-injection technique, Worst observed two anteroposterior canals, i.e., the canalis ciliobursale (a canal between the retrociliary cisterns reported by Worst and the BPM) and the canalis optico-lenticulare (a wider funnel-shaped canal between the Martegiani area and the BS surrounding the Cloquet’s canal) [5,27] and postulated that they play an important role in the transport of fluid, nutrients, and waste products through the vitreous [5]. We theorize that the transport of excess fluid and nutrients (e.g., lipids) and the excretion of waste products are the specific roles of the lymphatic system [37].
It should be noted that the cisternal system appears to be irregular and expanded compared with the usual lymphatic vessels [5,83]. However, we assume that the configuration of the cisterns and bursa in the vitreous resemble that of the primitive lymph sacs [84] from which lymphatic vessels and lymph nodes develop during the embryonic period [85,86]. Eisner observed that the prefoveal Lücke (lacuna or gap) that emerged in the premacular vitreous after maturation of the fovea had begun, was always extended into the vitreous center as a canal, and even reached the anterior vitreous [34,83]. Kishi et al. reported that the posterior precortical vitreous pocket was restricted to a small premacular area in the vitreous of infants yet expanded anteriorly with age and occasionally occupied more than half of the vitreous [21]. Los, a colleague of Worst, postulated that an age-related increase in the volume of the cisternal system would be consistent with a differentiation process rather than matrix degeneration based on the observation of dye-injected vitreous of various ages [87]. We speculate that Eisner, Kishi, and Los observed nearly the same structure in the developing vitreous and that an increase in the volume of the structure with age could be an analogy of the development of the primitive lymph sacs. Based on the findings above, the cisternal system reported by Worst appears to resemble the lymphatic (or perilymphatic) system, both functionally and developmentally.
The lymphatic vessels begin with blind-ended initial lymphatics that are composed of a single layer of lymphatic endothelial cells [88]. The anchoring filaments extend radially from the outer surface of the endothelial cells and connect to the surrounding connective tissue, such as elastic fibers [89]. Increased interstitial fluid pressure and dynamic movement of the tissue stretch the anchoring filaments and create gaps between neighboring lymphatic endothelial cells, through which interstitial fluid flows unidirectionally into the lymphatic vessels [90]. As we described above, podoplanin, LYVE-1, and fibrillin-1 and -2, which were all detected in the BS and BPM specimens, are components of lymph nodes. However, podoplanin and LYVE-1 are expressed in the lymphatic endothelial cells in the initial lymphatics [91] and the anchoring filaments mainly consist of fibrillin-1 and -2 [92,93]. Hence, it is possible that the initial lymphatic-like structure might exist in the BS and the BPM.
Worst et al. reported that the BPM surface is feathery or is surrounded by fine radiating lines [5]. When TA was injected into the posterior part of the vitreous during vitrectomy, the TA particles adhered exclusively to the anterior surfaces of the BPM and Martegiani area, presumably due to their feathery structure (Figure 1b) [5]. Furthermore, the surface appearance of the BPM described by Worst et al. [5] seems to resemble that of the initial lymphatics associated with the anchoring filaments [94]. Assuming that the surfaces of the BS and the BPM consist of an initial lymphatic-like structure, excess vitreous fluid might enter these tissues via increased intraocular pressure (IOP) and movement of the vitreous.
If our assumption regarding the function of the BS and the BPM is correct, the fluid entering these tissues would need to drain out of the eye. Until the 1960s, the theory of ocular lymph drainage had generally been discarded [95]. However, since then, several studies have shown that intravitreally injected materials, including India ink, radioactive tracers, and liposomes, drained into the cervical lymph nodes [95,96,97,98]. Those findings indicate that a communication between the vitreous cavity and the general lymphatic system might exist.
It is generally accepted that the aqueous humor produced in the ciliary body exits the eye either through the trabecular meshwork into the Schlemm’s canal (i.e., the conventional pathway) or through the ciliary muscle and other downstream tissues (i.e., the uveoscleral pathway) [99]. However, in 2009, the findings of Yücel et al. using lymphatic markers, podoplanin, and LYVE-1 proved the presence of lymphatic vessels in the ciliary body, thus suggesting that they are a third pathway for the drainage of aqueous humor [100].
We assume that the fluid entering the BPM might flow into the retrociliary cisterns through the canalis ciliobursale reported by Worst. Since the retrociliary cisterns are adjacent to the ciliary body [86], the fluid that enters the retrociliary cisterns might drain out into the lymphatic vessels in the ciliary body, draining into the superficial cervical lymph nodes [100,101].
The vitreous cavity is generally considered a closed system, with no direct interaction with the retrobulbar subarachnoid space [102]. However, numerous studies have investigated the drainage of the vitreous humor into the optic nerve [103]. In 1879, Kuhnt was the first to suggest that the papillary edema in elevated intracranial pressure was due to the stasis of lymphatic flow into the optic nerve sheath [104]. In 1884, Ulrich reported that the vitreous humor flowed into the optic nerve and then into the orbit of rabbits, and this findings was confirmed in other rabbit-model studies [105]. In 1979, Algvere reported that plastic microspheres injected into the central vitreous of rabbits moved toward the optic disc, where they subsequently converged around the central retinal artery [106].
The foveal retina is considered devoid of a paravascular channel, a component of the glymphatic system [107], due to its avascularity. However, a drainage pathway other than a paravascular space must be present to remove excess fluid from the fovea, as previously described. In 2018, Behar-Cohen et al. found that glial fibrillary acidic protein (GFAP)-positive cells that coexpress AQP4 are abundantly present at the roof of the human fovea [108]. In 2019, Ikeda et al. reported that the inner layer of the monkey fovea was mostly composed of GFAP-intensely positive astrocytes [109]. In 2020, Delaunay et al. reported that, in humans, connexin-43 and GFAP double-positive astrocytic glia cells cover the foveal pit [110]. Since AQP4-positive astrocytes contribute to the glymphatic system [108,111], a glymphatic clearance pathway associated with astrocytes could exist at the surface of the fovea.
Frisina et al. reported frequent observation of persistent or new cystoid macular edema (CME) following vitrectomy for ERM [112]. Worst postulated that the pathology of CME might be due to detachment of the BPM from the macula [8]. These findings indicate the possibility that the BPM might participate in the glymphatic clearance pathway involving astrocytes of the fovea and that excess interstitial fluid in the fovea might flow into the cisternal system via the BPM.
It should be noted that one limitation in this present study is that it was technically difficult to collect the BS and BPM specimens in an intact form during vitrectomy, thus explaining why we collected the specimens by cutting them into small pieces with a vitreous cutter. Hence, the BPM specimens that were obtained may have contained other tissues, including the Martegiani area, the septum interpapillo-maculare, and the posterior hyaloid membrane. We speculate that this is the reason why the staining patterns of the BPM were extremely different among the specimens, as shown in Figure 3. We consider that the BS as well as the BPM might be parenchymal tissues and that the histological findings of the specimens might reflect their inner structures. However, it is quite possible that these tissues might consist of hollow structures and that the specimens might be their walls. Therefore, it will be necessary to conduct further immunohistological studies using human cadaver eyes to determine the fine structures of the BS and the BPM.
The retrolental bursa described by Kislitsyna (i.e., the BS) and the premacular bursa described by Worst are adjacent to the posterior part of the lens and the macula, respectively, where pathological changes are frequently observed. Consequently, these tissues would be the most important parts in the vitreous, both physiologically and pathologically. Further investigation on the precise anatomy and physiological function of these tissues may provide clues to elucidate the pathogenesis mechanism of various ocular diseases, including cataracts, macular diseases, and glaucoma. It should be noted that it would be meaningful to study the relationship between such lymphoid tissues and the eye.

4. Materials and Methods

4.1. Collection of the BS, BPM, and VC Specimens

During vitrectomy, BPM and VC specimens were selectively collected from 6 eyes of 6 patients with MH (1 male and 5 females, age range: 62–79 years) and 2 eyes of 2 patients with ERM (1 male and 1 female, age 63 and 77 years, respectively) in which the BPM was clearly identified. All of those patients underwent both vitrectomy and cataract surgery at the same time. The vitreous specimens were collected in the same manner as previously described by Sato et al. [9]. Using a 25-gauge (G) transconjunctival sutureless vitrectomy system, the VC was collected with a vitreous cutter before the start of perfusion. To collect the BPM specimens, the vitreous was extensively resected, and TA was applied to visualize the BPM and the Martegiani area. Holes were then created in the anterior and posterior walls of the BPM with a diamond scraper. From these holes, vitreous fluid spontaneously flowed into the space between the BPM and the retina, resulting in the BPM being easily separated from the retinal surface by aspirating the edge of the hole in the anterior wall of the BPM with a vitreous cutter. Since the Martegiani area was connected to the BPM near the optic disc with a septal structure, both tissues were removed from the retina en bloc. Subsequently, the perfusate in the tube connected to the vitreous cutter was completely removed by injecting air into the connector in the reverse direction. The cutter was then reinserted into the vitreous cavity, and the BPM floating above the macula was selectively collected by reducing the rotation speed to 500/min.
From 4 eyes of 4 patients with MH (1 male and 3 females, age range: 64–75 years), the BS specimens were collected in addition to the BPM and VC specimens following the previously described method. To collect the BS specimens, TA was injected into it from behind under direct microscopy to visualize the interface between the BS and the surrounding vitreous. The posterior wall of the BS was then aspirated with a vitreous cutter and detached from the lens. After the perfusate in the tube was completely removed, as with the case of the BPM, the cutter was reinserted into the vitreous cavity to selectively collect BS specimens floating behind the lens. Informed written consent was obtained from all patients for involvement in the study.

4.2. Immunostaining of the BPM and VC with Antibodies for Fibrillin-1 and -2

Immunostaining with antibodies for fibrillin-1 (rabbit polyclonal, 1:300; Bioss Antibodies, Inc., Woburn, MA) and fibrillin-2 (rabbit polyclonal, 1:300; Bioss Antibodies) was performed in 3 eyes of 3 patients with MH (Cases 1–3) and in 1 eye of 1 patient with ERM (Case 4). After collection, the BPM and VC specimens were fixed with 4% paraformaldehyde, rinsed with phosphate buffer saline (PBS, pH 7.4), and blocked with 5% normal goat serum. Immunostaining was then performed by the avidin–biotin complex method with each target antibody. Next, the BPM and VC specimens were incubated with antibodies for fibrillin-1 and -2 at 4 °C for 2 days, rinsed with PBS, and incubated with biotinylated anti-rabbit immunoglobulin G (1:1000; Vector Laboratories, Inc., Burlingame, CA) at room temperature for 2 h. After a rinse with PBS, the specimens were incubated with alkaline phosphatase-labeled avidin–biotin complex (Vector Laboratories) at room temperature for 2 h and treated with an ImmPACT™ Vector® Red alkaline phosphatase substrate (Vector Laboratories). After dehydration, the specimens were enclosed with Entellan® new (Merck, KGaA, Darmstadt, Germany) and observed under a BZ-x700 microscope (Keyence Corporation, Osaka, Japan).

4.3. Immunostaining of the BS, BPM, and VC Specimens with Antibodies for Fibrillin-1 and -2, Podoplanin, and LYVE-1

BS, BPM, and VC specimens were selectively collected from 4 eyes of 4 patients with MH and ERM (Cases 5–8), and each specimen was immunostained with antibodies for fibrillin-1 and -2, podoplanin (rabbit polyclonal, 1:500; Abcam Inc., Cambridge, UK), and LYVE-1 (rabbit polyclonal, 1:500; Abcam). The BS, BPM, and VC specimens were stained in the manner described above.

Author Contributions

Conceptualization, S.M., K.N. and T.I.; methodology, S.M.,T.S., S.O., T.H. and T.I.; software, H.O.; validation, T.K., H.O. and T.I.; formal analysis, T.I.; investigation, S.M., T.K. and T.I.; resources, T.S., S.O. and T.I.; data curation, S.M. and T.H.; writing—original draft preparation, S.M.; writing—review and editing, T.K., H.O., K.N. and T.I.; visualization, T.I.; supervision, S.T. and D.J.; project administration, T.I.; funding acquisition, T.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was approved by the Ethics Committee of Osaka Medical College (Approval No. 1134), and was performed in accordance with the tenets set forth in the Declaration of Helsinki.

Informed Consent Statement

Informed written consent was obtained from all subjects prior to the preoperative blood test examination and the vitrectomy surgery being performed.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors wish to thank John Bush for reviewing the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

BPMbursa premacularis
PVDposterior vitreous detachment
LYVE-1lymphatic vessel endothelial hyaluronan receptor 1
BSBerger’s space
AHManterior hyaloid membrane
TAtriamcinolone acetonide
VCvitreous core
SS-OCTswept-source optical coherence tomography
ERMepiretinal membrane
MHmacular hole
PDRproliferative diabetic retinopathy
3D-OCTthree-dimensional optical coherence tomography
ABAAgaricus bisporus agglutinin
AQP4aquaporin-4
SD-OCTspectral domain optical coherence tomography
YAGyttrium aluminum garnet
IOPintraocular pressure
RPEretinal pigment epithelial
GFAPglial fibrillary acidic protein
CMEcystoid macular edema
PBSphosphate buffered saline

References

  1. Sebag, J. Structure of the vitreous. In The Vitreous-Structure, Function, and Pathobiology; Sebag, J., Ed.; Springer: New York, NY, USA, 1989; Volume 4, pp. 36–37, 133–135. ISBN 978-1-4613-8908-8. [Google Scholar]
  2. Swindle-Reilly, K.E.; Shah, M.; Hamilton, P.D.; Eskin, T.A.; Kaushal, S.; Ravi, N. Rabbit study of an in situ forming hydrogel vitreous substitute. Investig. Ophthalmol. Vis. Sci. 2009, 50, 4840–4846. [Google Scholar] [CrossRef]
  3. Sebag, J.S. Surgical anatomy of vitreous and the vitreoretinal interface. In Duane’s Ophthalmology; Sebag, J.S., Ed.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006; Volume 6, Chapter 51; ISBN 978-0781753296. [Google Scholar]
  4. Eisner, G. Postmortem slitlamp study of the vitreous body I-III. Graefe’s Arch. Klin. Exp. Ophthalmol. 1971, 182, 1–40. [Google Scholar] [CrossRef]
  5. Worst, J.G.; Los, L.I. Comparative anatomy of the vitreous body in rhesus monkeys and man. Doc. Ophthalmol. 1992, 82, 169–178. [Google Scholar] [CrossRef]
  6. Worst, J.G. Cisternal systems of the fully developed vitreous body in the young adult. Trans. Ophthalmol. Soc. UK 1977, 97, 550–554. [Google Scholar] [PubMed]
  7. Worst, J.G.F. The bursa intravitrealis premacularis. In New Developments in Ophthalmology Nijmegen 16–18 October 1975; Duetman, A.F., Ed.; Springer: New York, NY, USA, 1975; pp. 275–279. ISBN 978-9061941478. [Google Scholar]
  8. Worst, J. Extracapsular surgery in lens implantation (Binkhorst lecture). Part iv. Some anatomical and pathophysiological implications. J. Am. Intraocul. Implant Soc. 1978, 4, 7–14. [Google Scholar] [CrossRef]
  9. Sato, T.; Morishita, S.; Horie, T.; Fukumoto, M.; Kida, T.; Oku, H.; Nakamura, K.; Takai, S.; Jin, D.; Ikeda, T. Involvement of premacular mast cells in the pathogenesis of macular diseases. PLoS ONE 2019, 14, e0211438. [Google Scholar] [CrossRef]
  10. Santos-Bueso, E. Berger’s space. Arch. Soc. Esp. Oftalmol. 2019, 94, 471–477. [Google Scholar] [CrossRef]
  11. Li, S.T.; Yiu, E.P.; Wong, A.H.; Yeung, J.C.; Yu, L.W. Management of traumatic haemorrhage in the Berger’s space of a 4-year-old child. Int. Ophthalmol. 2017, 37, 1053–1055. [Google Scholar] [CrossRef] [PubMed]
  12. Turgut, B.; Türkçüoğlu, P.; Deniz, N.; Catak, O. Annular and central heavy pigment deposition on the posterior lens capsule in the pigment dispersion syndrome: Pigment deposition on the posterior lens capsule in the pigment dispersion syndrome. Int. Ophthalmol. 2008, 28, 441–445. [Google Scholar] [CrossRef]
  13. Tanaka, H.; Ohara, K.; Shiwa, T.; Minami, M. Idiopathic opacification of Berger’s space. J. Cataract Refract. Surg. 2004, 30, 2232–2234. [Google Scholar] [CrossRef]
  14. Mares, V.; Nehemy, M.B.; Salomao, D.R.; Goddard, S.; Tesmer, J.; Pulido, J.S. Multimodal imaging and histopathological evaluation of Berger’s Space. Ocul. Oncol. Pathol. 2020, 6, 3–9. [Google Scholar] [CrossRef] [PubMed]
  15. Mansukhani, S.A.; Pulido, J.S.; Khanna, S.S. Nd:YAG capsulotomy for the management of posterior capsular amyloidosis. Am. J. Ophthalmol. Case Rep. 2018, 13, 50–52. [Google Scholar] [CrossRef]
  16. Kislitsyna, N.; Novikov, S.; Kolesnik, A.; Kolesnik, S.; Veselkova, M. On the inner side of lens. Anatomic and topographic features of anterior vitreous. In Proceedings of the 2019 EVRS Congress, Lisbon, Portugal, 27–30 June 2019. [Google Scholar]
  17. Kislitsyna, N.; Novikov, S.; Kolesnik, A.; Kolesnik, S.; Veselkova, M. Anatomical topographical features of anterior vitreous cortex. Fyodrov J. Ophthalmic Surg. 2017, 1, 66–71. [Google Scholar] [CrossRef]
  18. Sebag, J. Vitreous: The resplendent enigma. Br. J. Ophthalmol. 2009, 93, 989–991. [Google Scholar] [CrossRef] [PubMed]
  19. Kishi, S. Impact of swept source optical coherence tomography on ophthalmology. Taiwan J. Ophthalmol. 2016, 6, 58–68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Kishi, S.; Shimizu, K. Oval defect in detached posterior hyaloid membrane in idiopathic preretinal macular fibrosis. Am. J. Ophthalmol. 1994, 118, 451–456. [Google Scholar] [CrossRef]
  21. Kishi, S.; Shimizu, K. Posterior precortical vitreous pocket. Arch. Ophthalmol. 1990, 108, 979–982. [Google Scholar] [CrossRef] [PubMed]
  22. Engelbert, M. A new understanding of vitreous structure. Rev. Ophthalmol. 2016, 1, 60–64. [Google Scholar]
  23. Itakura, H.; Kishi, S.; Li, D.; Akiyama, H. Observation of posterior precortical vitreous pocket using swept-source optical coherence tomography. Investig. Ophthalmol. Vis. Sci. 2013, 54, 3102–3107. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Worst, J.G.F.; Sebag, J.; Kishi, S. Posterior precortical vitreous pocket. Arch. Ophthalmol. 1991, 109, 1058–1060. [Google Scholar] [CrossRef]
  25. Kakehashi, A.; Kado, M.; Akiba, J.; Hirokawa, H. Variations of posterior vitreous detachment. Br. J. Ophthalmol. 1997, 81, 527–532. [Google Scholar] [CrossRef]
  26. Kakehashi, A.; Kado, M.; Akiba, J.; Hirokawa, H. Biomicroscopic findings of posterior vitreous. Nippon Ganka Gakkai Zasshi 1995, 99, 323–328. [Google Scholar]
  27. She, X.; Ye, X.; Chen, R.; Pan, D.; Shen, L. Characteristics of posterior precortical vitreous pockets and Cloquet’s canal in patients with myopia by optical coherence tomography. Investig. Ophthalmol. Vis. Sci. 2019, 60, 4882–4888. [Google Scholar] [CrossRef] [Green Version]
  28. Polak, B.C.P.; Ringens, P.J.; Worst, J.G.F. Physiological vitreous changes may contribute to the pathogenesis of macular degeneration. Acta Ophthalmol. 2012, 90, e652–e653. [Google Scholar] [CrossRef] [PubMed]
  29. Kishi, S. The vitreous and the macula. Nippon Ganka Gakkai Zasshi 2015, 119, 117–143. (In Japanese) [Google Scholar] [PubMed]
  30. Okada, M.; Ogino, N.; Matsumura, M.; Honda, Y.; Nagai, Y. Histological and immunohistochemical study of idiopathic epiretinal membrane. Ophthalmic Res. 1995, 27, 118–128. [Google Scholar] [CrossRef]
  31. Sebag, J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol. 2008, 246, 329–332. [Google Scholar] [CrossRef] [Green Version]
  32. Sebag, J.; Niemeyer, M.; Koss, M.J. Anomalous posterior vitreous detachment and vitreoschisis. In Vitreous: In Health and Disease; Sebag, J., Ed.; Springer Publishing Company: New York, NY, USA, 2014; pp. 241–263. ISBN 978-1-4939-1086-1. [Google Scholar]
  33. Gupta, P.; Yee, K.M.; Garcia, P.; Rosen, R.B.; Parikh, J.; Hageman, G.S.; Sadun, A.A.; Sebag, J. Vitreoschisis in macular diseases. Br. J. Ophthalmol. 2011, 95, 376–380. [Google Scholar] [CrossRef] [PubMed]
  34. Eisner, G. Gross anatomy of the vitreous body (author’s trans). Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 1975, 193, 33–56. [Google Scholar] [CrossRef]
  35. Kishi, S.; Hagimura, N.; Shimizu, K. The role of the premacular liquified pocket and premacular vitreous cortex in idiopathic macular hole development. Am. J. Ophthalmol. 1996, 122, 622–628. [Google Scholar] [CrossRef]
  36. Itakura, H.; Kishi, S. Aging changes of vitreomacular interface. Retina 2011, 31, 1400–1404. [Google Scholar] [CrossRef] [PubMed]
  37. Kesler, C.T.; Liao, S.; Munn, L.L.; Padera, T.P. Lymphatic vessels in health and disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 2013, 5, 111–124. [Google Scholar] [CrossRef] [Green Version]
  38. Isogai, S.; Hitomi, J.; Yaniv, K.; Weinstein, B.M. Zebrafish as a new animal model to study lymphangiogenesis. Anat. Sci. Int. 2009, 84, 102–111. [Google Scholar] [CrossRef] [PubMed]
  39. Alderfer, L.; Wei, A.; Hanjaya-Putra, D. Lymphatic Tissue Engineering and Regeneration. J. Biol. Eng. 2018, 17, 12–32. [Google Scholar] [CrossRef]
  40. Aspelund, A.; Antila, S.; Proulx, S.T.; Karlsen, T.V.; Karaman, S.; Detmar, M.; Wiig, H.; Alitalo, K. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 2015, 212, 991–999. [Google Scholar] [CrossRef]
  41. Iliff, J.J.; Wang, M.; Liao, Y.; Plogg, B.A.; Peng, W.; Gundersen, G.A.; Benveniste, H.; Vates, G.E.; Deane, R.; Goldman, S.A.; et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 2012, 4, 147ra111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Burfeind, K.G.; Murchison, C.F.; Westaway, S.K.; Simon, M.J.; Erten-Lyons, D.; Kaye, J.A.; Quinn, J.F.; Iliff, J.J. The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer’s disease. Alzheimers Dement (N.Y.) 2017, 3, 348–359. [Google Scholar] [CrossRef] [PubMed]
  43. Bucchieri, F.; Farina, F.; Zummo, G.; Cappello, F. Lymphatic vessels of the dura mater: A new discovery? J. Anat. 2015, 227, 702–703. [Google Scholar] [CrossRef] [Green Version]
  44. Raper, D.; Louveau, A.; Kipnis, J. How do meningeal lymphatic vessels drain the CNS? Trends Neurosci. 2016, 39, 581–586. [Google Scholar] [CrossRef] [Green Version]
  45. Ford, M.L. How brains are drained: Discovery of lymphatics within the CNS. Am. J. Transpl. 2016, 3, 735. [Google Scholar] [CrossRef] [Green Version]
  46. London, A.; Benhar, I.; Schwartz, M. The retina as a window to the brain-from eye research to CNS disorders. Nat. Rev. Neurol. 2013, 9, 44–53. [Google Scholar] [CrossRef]
  47. Nakao, S.; Hafezi-Moghadam, A.; Ishibashi, T. Lymphatics and lymphangiogenesis in the eye. J. Ophthalmol. 2012, 2012, 783163. [Google Scholar] [CrossRef] [PubMed]
  48. Wostyn, P.; van Dam, D.; Audenaert, K.; Killer, H.E.; de Deyn, P.P.; de Groot, V. A new glaucoma hypothesis: A role of glymphatic system dysfunction. Fluids Barriers CNS 2015, 12, 16. [Google Scholar] [CrossRef] [Green Version]
  49. Denniston, A.K.; Keane, P.A. Paravascular Pathways in the Eye: Is There an ‘Ocular Glymphatic System’? Investig. Ophthalmol. Vis. Sci. 2015, 56, 3955–3956. [Google Scholar] [CrossRef]
  50. Wostyn, P.; De Groot, V.; Van Dam, D.; Audenaert, K.; Killer, H.E.; De Deyn, P.P. Age-related macular degeneration, glaucoma and Alzheimer’s disease: Amyloidogenic diseases with the same glymphatic background? Cell Mol. Life Sci. 2016, 3, 4299–4301. [Google Scholar] [CrossRef] [PubMed]
  51. Wostyn, P.; de Groot, V.; van Dam, D.; Audenaert, K.; de Deyn, P.P. The Glymphatic System: A New Player in Ocular Diseases? Investig. Ophthalmol. Vis. Sci. 2016, 57, 5426–5427. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Gausas, R.E.; Daly, T.; Fogt, F. D2-40 expression demonstrates lymphatic vessel characteristics in the dural portion of the optic nerve sheath. Ophthalmic Plast. Reconstr. Surg. 2007, 23, 32–36. [Google Scholar] [CrossRef] [PubMed]
  53. Xu, X.; Gimotty, P.A.; Guerry, D.; Karakousis, G.; Elder, D.E. Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma. Methods Mol. Biol. 2014, 1102, 275–286. [Google Scholar] [CrossRef] [Green Version]
  54. Morgado, F.N.; da Silva, A.V.A.; Porrozzi, R. Infectious diseases and the lymphoid extracellular matrix remodeling: A focus on conduit system. Cells 2020, 9, 725. [Google Scholar] [CrossRef] [Green Version]
  55. Palframan, R.T.; Jung, S.; Cheng, G.; Weninger, W.; Luo, Y.; Dorf, M.; Littman, D.R.; Rollins, B.J.; Zweerink, H.; Rot, A.; et al. Inflammatory chemokine transport and presentation in HEV: A remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 2001, 194, 1361–1373. [Google Scholar] [CrossRef] [Green Version]
  56. Roozendaal, R.; Mempel, T.R.; Pitcher, L.A.; Gonzalez, S.F.; Verschoor, A.; Mebius, R.E.; von Andrian, U.H.; Carroll, M.C. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity. 2009, 30, 264–276. [Google Scholar] [CrossRef] [Green Version]
  57. Drumea-Mirancea, M.; Wessels, J.T.; Müller, C.A.; Essl, M.; Eble, J.A.; Tolosa, E.; Koch, M.; Reinhardt, D.P.; Sixt, M.; Sorokin, L.; et al. Characterization of a conduit system containing laminin-5 in the human thymus: A potential transport system for small molecules. J. Cell Sci. 2006, 119, 1396–1405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Nolte, M.A.; Beliën, J.A.M.; Schadee-Eestermans, I.; Jansen, W.; Unger, W.W.J.; van Rooijen, N.; Kraal, G.; Mebius, R.E. A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J. Exp. Med. 2003, 198, 505–512. [Google Scholar] [CrossRef] [PubMed]
  59. Pegu, A.; Flynn, J.L.; Reinhart, T.A. Afferent and efferent interfaces of lymph nodes are distinguished by expression of lymphatic endothelial markers and chemokines. Lymphat. Res. Biol. 2007, 5, 91–103. [Google Scholar] [CrossRef] [PubMed]
  60. Noda, Y.; Amano, I.; Hata, M.; Kojima, H.; Sawa, Y. Immunohistochemical examination on the distribution of cells expressed lymphatic endothelial marker podoplanin and LYVE-1 in the mouse tongue tissue. Acta. Histochem. Cytochem. 2010, 43, 61–68. [Google Scholar] [CrossRef] [Green Version]
  61. Wang, H.W.; Tedla, N.; Lloyd, A.R.; Wakefield, D.; McNeil, P.H. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Investig. 1998, 102, 1617–1626. [Google Scholar] [CrossRef] [Green Version]
  62. Lobov, G.I.; Pan’kova, M.N. Mechanical properties of lymph node capsule. Bull. Exp. Biol. Med. 2011, 151, 5–8. [Google Scholar] [CrossRef] [PubMed]
  63. Bouta, E.M.; Ju, Y.; Rahimi, H.; de Mesy-Bentley, K.L.; Wood, R.W.; Xing, L.; Schwarz, E.M. Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis. PLoS ONE 2013, 8, e73766. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Scelsi, R.; Scelsi, L.; Cortinovis, R.; Poggi, P. Morphological changes of dermal blood and lymphatic vessels in chronic venous insufficiency of the leg. Int. Angiol. 1994, 13, 308–311. [Google Scholar]
  65. Bouta, E.M.; Wood, R.W.; Brown, E.B.; Rahimi, H.; Ritchlin, C.T.; Schwarz, E.M. In vivo quantification of lymph viscosity and pressure in lymphatic vessels and draining lymph nodes of arthritic joints in mice. J. Physiol. 2014, 592, 1213–1223. [Google Scholar] [CrossRef]
  66. Jongebloed, W.L.; Humalda, D.; Worst, J.F. A SEM-correlation of the anatomy of the vitreous body: Making visible the invisible. Doc. Ophthalmol. 1986, 64, 117–127. [Google Scholar] [CrossRef] [PubMed]
  67. Bogoslowski, A.; Kubes, P. Lymph nodes: The unrecognized barrier against pathogens. ACS Infect. Dis. 2018, 4, 1158–1161. [Google Scholar] [CrossRef] [PubMed]
  68. Williams, G.M.; Nossal, G.J. Ontogeny of the immune response. I. The development of the follicular antigen-trapping mechanism. J. Exp. Med. 1966, 124, 47–56. [Google Scholar] [CrossRef] [Green Version]
  69. Tassignon, M.J.; Dhubhghaill, S.N. Real-time intraoperative optical coherence tomography imaging confirms older concepts about the Berger space. Ophthalmic Res. 2016, 56, 222–226. [Google Scholar] [CrossRef] [PubMed]
  70. Cradock, K.A.; Liu, Z.G.; Ray, P.S.; Boppart, S.A. Intraoperative optical coherence tomography for assessing human lymph nodes for metastatic cancer. BMC Cancer 2016, 23, 16–144. [Google Scholar] [CrossRef] [Green Version]
  71. Qureshi, N.; Abbas, M.; Ishaque, N.; Chaudhry, M.M.; Hameed, M. Neodymium: YAG laser treatment for dense premacular subhyaloid hemorrhage. JLUMHS 2008, 1, 34–36. [Google Scholar] [CrossRef]
  72. Kumar, V.; Goel, N. “Arcus retinalis”: A novel clinical marker of sub-internal limiting membrane hemorrhage. Eur. J. Ophthalmol. 2020, 22, 1120672120934958. [Google Scholar] [CrossRef]
  73. Morris, R.; Kuhn, F.; Witherspoon, C.D.; Mester, V.; Dooner, J. Hemorrhagic macular cysts in Terson’s syndrome and its implications for macular surgery. Dev. Ophthalmol. 1997, 29, 44–54. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Sakamoto, M.; Nakamura, K.; Shibata, M.; Yokoyama, K.; Matsuki, M.; Ikeda, T. Magnetic resonance imaging findings of Terson’s syndrome suggesting a possible vitreous hemorrhage mechanism. Jpn. J. Ophthalmol. 2010, 54, 135–139. [Google Scholar] [CrossRef]
  75. Meyer, C.H.; Mennel, S.; Rodrigues, E.B.; Schmidt, J.C. Is the location of valsalva hemorrhages submembranous or subhyaloidal? Am. J. Ophthalmol. 2006, 41, 231. [Google Scholar] [CrossRef] [PubMed]
  76. Jongebloed, W.L.; Worst, J.F. The cisternal anatomy of the vitreous body. Doc Ophthalmol. 1987, 67, 183–196. [Google Scholar] [CrossRef] [PubMed]
  77. Ikeda, T.; Sato, K.; Katano, T.; Hayashi, Y. Surgically induced detachment of the anterior hyaloid membrane from the posterior lens capsule. Arch. Ophthalmol. 1999, 117, 408–409. [Google Scholar] [CrossRef] [Green Version]
  78. Fine, H.F.; Spaide, R.F. Visualization of the posterior precortical vitreous pocket in vivo with triamcinolone. Arch. Ophthalmol. 2006, 124, 1663. [Google Scholar] [CrossRef] [PubMed]
  79. Shimada, H.; Nakashizuka, H.; Hattori, T.; Mori, R.; Mizutani, Y.; Yuzawa, M. Three-dimensional depiction of the vitreous pocket using triamcinolone acetonide. Eur. J. Ophthalmol. 2009, 19, 1102–1105. [Google Scholar] [CrossRef] [PubMed]
  80. Streeten, B.W.; Pulaski, J.P. Posterior zonules and lens extraction. Arch. Ophthalmol. 1978, 96, 132–138. [Google Scholar] [CrossRef] [PubMed]
  81. Bergua, A.; Küchle, M. Visualization of the hyalo-capsular ligament in the living eye. Graefes Arch. Clin. Exp. Ophthalmol. 2002, 240, 503–505. [Google Scholar] [CrossRef]
  82. Kawagoe, M.; Tsuruga, E.; Oka, K.; Sawa, Y.; Ishikawa, H. Matrix metalloproteinase-2 degrades fibrillin-1 and fibrillin-2 of oxytalan fibers in the human eye and periodontal ligaments in vitro. Acta Histochem. Cytochem. 2013, 46, 153–159. [Google Scholar] [CrossRef] [Green Version]
  83. Worst, J.F.G.; Los, L.I. Cisternal Anatomy of the Vitreous; Kugler Publications: Amsterdam, The Netherlands, 1995; pp. 5, 26. ISBN 978-9062991105. [Google Scholar]
  84. Oliver, G.; Detmar, M. The rediscovery of the lymphatic system: Old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002, 16, 773–783. [Google Scholar] [CrossRef] [Green Version]
  85. Van de Pavert, S.A.; Mebius, R.E. Development of secondary lymphoid organs in relation to lymphatic vasculature. Adv. Anat. Embryol. Cell Biol. 2014, 214, 81–91. [Google Scholar] [CrossRef]
  86. Díaz-Flores, L.; Gutiérrez, R.; García, M.P.; González-Gómez, M.; Díaz-Flores, L., Jr.; Carrasco, J.L. Intussusceptive lymphangiogenesis in the sinuses of developing human foetal lymph nodes. Ann. Anat. 2019, 226, 73–83. [Google Scholar] [CrossRef]
  87. Los, L.I. The rabbit as an animal model for post-natal vitreous matrix differentiation and degeneration. Eye (Lond.) 2008, 22, 1223–1232. [Google Scholar] [CrossRef] [Green Version]
  88. Breslin, J.W.; Yang, Y.; Scallan, J.P.; Sweat, R.S.; Adderley, S.P.; Murfee, W.L. Lymphatic vessel network structure and physiology. Compr. Physiol. 2018, 9, 207–299. [Google Scholar] [CrossRef] [PubMed]
  89. Scavelli, C.; Weber, E.; Aglianò, M.; Cirulli, T.; Nico, B.; Vacca, A.; Ribatti, D. Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J. Anat. 2004, 204, 433–449. [Google Scholar] [CrossRef]
  90. Bazigou, E.; Wilson, J.T.; Moore, J.E., Jr. Primary and secondary lymphatic valve development: Molecular, functional and mechanical insights. Microvasc. Res. 2014, 96, 38–45. [Google Scholar] [CrossRef] [Green Version]
  91. Gerli, R.; Solito, R.; Weber, E.; Aglianó, M. Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology 2000, 33, 148–157. [Google Scholar]
  92. Weber, E.; Rossi, A.; Solito, R.; Sacchi, G.; Agliano, M.; Gerli, R. Focal adhesion molecules expression and fibrillin deposition by lymphatic and blood vessel endothelial cells in culture. Microvasc. Res. 2002, 64, 47–55. [Google Scholar] [CrossRef]
  93. Quondamatteo, F.; Reinhardt, D.P.; Charbonneau, N.L.; Pophal, G.; Sakai, L.Y.; Herken, R. Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. Matrix Biol. 2002, 21, 637–646. [Google Scholar] [CrossRef]
  94. Paniagua, D.; Vergara, I.; Boyer, L.; Alagón, A. Role of lymphatic system on snake venome absorption. In Snake Venoms. Toxinology; Gopalakrishnakone, P., Inagaki, H., Vogel, C.W., Mukherjee, A.K., Rahmy, T.R., Eds.; Springer Science + Business Media: Dordrecht, The Netherlands, 2017; Volume 19, pp. 453–477. ISBN 978-94-007-6409-5. [Google Scholar]
  95. Grüntzig, J.; Huth, F. Studies on the lymphatic drainage of the eye. 3. Observations of the drainage of Indian ink from the vitreous after bilateral cervical lymph node dissection (author’s transl). Klin. Monbl. Augenheilkd. 1977, 171, 774–779, (Article in German). [Google Scholar] [PubMed]
  96. Grüntzig, J.; Schicha, H.; Becker, V.; Keim, J.; Feinendegen, L.E. Studies of the lymph drainage of the eye. 4. Drainage of lymphotropic radioactive tracers (99mTc-Microcolloid) after intravitreal injection. Klin. Monbl. Augenheilk. 1978, 172, 87–94. (In German) [Google Scholar]
  97. Grüntzig, J.; Schicha, H.; Huth, F. Eye and lymph drainage. Z. Lymphol. 1979, 3, 35–45. (In German) [Google Scholar] [PubMed]
  98. Camelo, S.; Lajavardi, L.; Bochot, A.; Goldenberg, B.; Naud, M.C.; Fattal, E.; Behar-Cohen, F.; de Kozak, Y. Drainage of fluorescent liposomes from the vitreous to cervical lymph nodes via conjunctival lymphatics. Ophthalmic Res. 2008, 40, 145. [Google Scholar] [CrossRef] [PubMed]
  99. Goel, M.; Picciani, R.G.; Lee, R.K.; Bhattacharya, S.K. Aqueous humor dynamics: A review. Open Ophthalmol. J. 2010, 4, 52–59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  100. Yücel, Y.H.; Johnston, M.G.; Ly, T.; Patel, M.; Drake, B.; Gümüş, E.; Fraenkl, S.A.; Moore, S.; Tobbia, D.; Armstrong, D.; et al. Identification of lymphatics in the ciliary body of the human eye: A novel “uveolymphatic” outflow pathway. Exp. Eye Res. 2009, 89, 810–819. [Google Scholar] [CrossRef] [PubMed]
  101. Grüntzig, J.; Hollmann, F. Lymphatic vessels of the eye—old questions—new insights. Ann. Anat. 2019, 221, 1–16. [Google Scholar] [CrossRef]
  102. Caglı, B.; Tuncel, S.A.; Yılmaz, E.; Tekatas, A.; Ermıs, V. Vitreous humor diffusion measurements from diffusion weighted imaging in idiopathic intracranial hypertension. Ideggyogy. Szle. 2016, 69, 405–410. [Google Scholar] [CrossRef]
  103. Hayreh, S.S. Posterior drainage of the intraocular fluid from the vitreous. Exp. Eye Res. 1966, 5, 123–144. [Google Scholar] [CrossRef]
  104. Kuhnt, H. L’oedema papillaire. Ann. Ocul. 1879, 82, 180. [Google Scholar]
  105. Ulrich, R. Studien über die Pathogenese des Glaucoms. Graefe’s Arch. Fur Ophthalmol. 1884, 30, 235–288. [Google Scholar] [CrossRef] [Green Version]
  106. Algvere, P.; Bill, A. Drainage of microspheres and RBCs from the vitreous of aphakic and phakic eyes. Arch. Ophthalmol. 1979, 97, 1333–1336. [Google Scholar] [CrossRef]
  107. Faghih, M.M.; Sharp, M.K. Is bulk flow plausible in perivascular, paravascular and paravenous channels? Fluids Barriers CNS 2018, 15, 17. [Google Scholar] [CrossRef] [PubMed]
  108. Behar-Cohen, F.F.; Moulin, A.; Jonet, L.; Gelize, E.; Sellam, A.; Crisanti, P. Aquaporin 4 and glymphatic drainage in the human macula. Investig. Ophthalmol. Vis. Sci. 2018, 59, 388. [Google Scholar]
  109. Ikeda, T.; Nakamura, K.; Oku, H.; Horie, T.; Kida, T.; Takai, S. Immunohistological study of monkey foveal retina. Sci. Rep. 2019, 9, 5258. [Google Scholar] [CrossRef] [PubMed]
  110. Delaunay, K.; Khamsy, L.; Kowalczuk, L.; Moulin, A.; Nicolas, M.; Zografos, L.; Lassiaz, P.; Behar-Cohen, F. Glial cells of the human fovea. Mol. Vis. 2020, 26, 235–245. [Google Scholar] [PubMed]
  111. Mader, S.; Brimberg, L. Aquaporin-4 water channel in the brain and its implication for health and disease. Cells 2019, 8, 90. [Google Scholar] [CrossRef] [Green Version]
  112. Frisina, R.; Pinackatt, S.J.; Sartore, M.; Monfardini, A.; Baldi, A.; Cesana, B.M.; Semerato, C.F.; Bratu, A.; Parolini, B. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch. Clin. Exp. Ophthalmol. 2015, 253, 47–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Surgical procedure used to obtain the bursa premacularis (BPM) specimens. Triamcinolone acetonide (TA) particles were firmly adhered to only the surfaces of the BPM and the Martegiani area. The BPM was observed to be an oval or round thin tissue with a size of 5 to 6 disc diameters on the macula (a). Two penetrating holes were easily created in the anterior and posterior walls of the BPM by surgically scraping the surface with a diamond scraper (b,c); black arrowheads). Firm adhesion with a circular ligamentous structure was observed in the periphery of the BPM (c; thin black arrows), and this adhesion extended to the Martegiani area that also firmly adhered to the retina around the optic disc. The combined specimen of the BPM and Martegiani area was then separated from the retina via aspiration of the edge of the hole in the anterior wall of the BPM with a vitreous cutter. The tissue specimen was then released into the vitreous and selectively collected with a vitreous cutter (d).
Figure 1. Surgical procedure used to obtain the bursa premacularis (BPM) specimens. Triamcinolone acetonide (TA) particles were firmly adhered to only the surfaces of the BPM and the Martegiani area. The BPM was observed to be an oval or round thin tissue with a size of 5 to 6 disc diameters on the macula (a). Two penetrating holes were easily created in the anterior and posterior walls of the BPM by surgically scraping the surface with a diamond scraper (b,c); black arrowheads). Firm adhesion with a circular ligamentous structure was observed in the periphery of the BPM (c; thin black arrows), and this adhesion extended to the Martegiani area that also firmly adhered to the retina around the optic disc. The combined specimen of the BPM and Martegiani area was then separated from the retina via aspiration of the edge of the hole in the anterior wall of the BPM with a vitreous cutter. The tissue specimen was then released into the vitreous and selectively collected with a vitreous cutter (d).
Ijms 22 02086 g001
Figure 2. Surgical procedure used to obtain the Berger’s space (BS) specimens. TA was injected into the BS from behind during vitrectomy in order to visualize the configuration (a). The periphery of the BS was firmly adhered to the lens with a circular ligamentous structure, known as Wieger’s ligament (a; white arrowheads). A septum-like structure appeared to divide the BS into a two-thirds temporal and one-third nasal formation (b; black arrowheads). The BS specimen was then separated from the lens via aspiration of its posterior wall with a vitreous cutter. The specimen was then released into the vitreous cavity and selectively collected with the vitreous cutter.
Figure 2. Surgical procedure used to obtain the Berger’s space (BS) specimens. TA was injected into the BS from behind during vitrectomy in order to visualize the configuration (a). The periphery of the BS was firmly adhered to the lens with a circular ligamentous structure, known as Wieger’s ligament (a; white arrowheads). A septum-like structure appeared to divide the BS into a two-thirds temporal and one-third nasal formation (b; black arrowheads). The BS specimen was then separated from the lens via aspiration of its posterior wall with a vitreous cutter. The specimen was then released into the vitreous cavity and selectively collected with the vitreous cutter.
Ijms 22 02086 g002
Figure 3. Immunostaining of the BPM specimen with antibodies for fibrillin-1. The vitreous core (VC) of patients with a macular hole (MH) and with an epiretinal membrane (ERM) was faintly stained with antibodies for fibrillin-1 (a), whereas the BPM was intensely stained (b).
Figure 3. Immunostaining of the BPM specimen with antibodies for fibrillin-1. The vitreous core (VC) of patients with a macular hole (MH) and with an epiretinal membrane (ERM) was faintly stained with antibodies for fibrillin-1 (a), whereas the BPM was intensely stained (b).
Ijms 22 02086 g003
Figure 4. Immunostaining of the BPM with antibodies for fibrillin-2. Similar to fibrillin-1, the VC of patients with MH and ERM was faintly stained with antibodies for fibrillin-2 (a) whereas the BPM was intensely stained (b).
Figure 4. Immunostaining of the BPM with antibodies for fibrillin-2. Similar to fibrillin-1, the VC of patients with MH and ERM was faintly stained with antibodies for fibrillin-2 (a) whereas the BPM was intensely stained (b).
Ijms 22 02086 g004
Figure 5. Immunostaining of the VC (a), BPM (b), and BS (c) with antibodies for fibrillin-1 and -2, podoplanin, and LYVE-1. Similar to the BPM, the BS of the patients with MH was more intensely stained for fibrillin-1 and -2 and for podoplanin than was the VC. In addition, the BPM and the BS of the patients with ERM were more intensely stained with antibodies for LYVE-1 than was the VC. The staining pattern of the BS closely resembled that of the BPM.
Figure 5. Immunostaining of the VC (a), BPM (b), and BS (c) with antibodies for fibrillin-1 and -2, podoplanin, and LYVE-1. Similar to the BPM, the BS of the patients with MH was more intensely stained for fibrillin-1 and -2 and for podoplanin than was the VC. In addition, the BPM and the BS of the patients with ERM were more intensely stained with antibodies for LYVE-1 than was the VC. The staining pattern of the BS closely resembled that of the BPM.
Ijms 22 02086 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Morishita, S.; Sato, T.; Oosuka, S.; Horie, T.; Kida, T.; Oku, H.; Nakamura, K.; Takai, S.; Jin, D.; Ikeda, T. Expression of Lymphatic Markers in the Berger’s Space and Bursa Premacularis. Int. J. Mol. Sci. 2021, 22, 2086. https://doi.org/10.3390/ijms22042086

AMA Style

Morishita S, Sato T, Oosuka S, Horie T, Kida T, Oku H, Nakamura K, Takai S, Jin D, Ikeda T. Expression of Lymphatic Markers in the Berger’s Space and Bursa Premacularis. International Journal of Molecular Sciences. 2021; 22(4):2086. https://doi.org/10.3390/ijms22042086

Chicago/Turabian Style

Morishita, Seita, Takaki Sato, Shou Oosuka, Taeko Horie, Teruyo Kida, Hidehiro Oku, Kimitoshi Nakamura, Shinji Takai, Denan Jin, and Tsunehiko Ikeda. 2021. "Expression of Lymphatic Markers in the Berger’s Space and Bursa Premacularis" International Journal of Molecular Sciences 22, no. 4: 2086. https://doi.org/10.3390/ijms22042086

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop